This is excellent news!
Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year DataMay 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic valves with the company's innovative RESILIA tissue. The data, which represent the longest clinical follow-up for Edwards'...www.dicardiology.com
Important also to note, from the linked article regarding 7 year outcomes:
"The seven-year data from the COMMENCE aortic trial demonstrates strong clinical outcomes and excellent durability in a study of younger patients with a mean age of 65.1 years."
It comes back to what the public identifies as "young" vs what "young" means in the valve surgery world, very much like the meme Pellicle posted a few posts upstream. Yes, a person who is 65 is young in the valve surgery world. And, if a patient is under 50, well, that's basically a toddler.